Mastery EAQ Ch. 12

A  0.2 mg (2 mL) IV over 15 seconds

B  0.2 mg (2 mL) IV over 60 seconds

C  0.2 mg (2 mL) intravenously (IV) over 30 seconds

D  0.5 mg (5 mL) IV over 30 seconds

A  “Nowadays I sleep for long hours.”

B  “I sleep less than I used to.”

C  “I often feel dizzy and lightheaded.”

D  “I feel like I breathe too deeply.”

A  Zaleplon

B  Ramelteon

C  Eszopiclone

D  Alprazolam

A  The half-life of flumazenil is short.

B  0.2 mg (2 mL) of flumazenil was given intravenously (IV).

C  Alcohol was consumed with the benzodiazepines.

D  A high dose of flumazenil was given.

A  Level of consciousness

B  Indicators of infection

C  Amount of bleeding

D  Muscle spasms

A  Airway maintenance

B  Seizure precautions

C  Comfort measures

D  Antidote preparation

A  Monitoring the patient’s renal and hepatic function

B  Assessing the patient’s risk for injury or falls

C  Monitoring for suicidal tendencies

D  Encouraging the patient to drink more fluids

A  Diazepam

B  Baclofen

C  Zaleplon

D  Pentobarbital

A  Temazepam

B  Eszopiclone

C  Alprazolam

D  Clonazepam

A  Liver dysfunction

B  Bronchial asthma

C  Kidney dysfunction

D  Narrow-angle glaucoma

A  Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

B  Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

C  Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

D  Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

A  Takes rifampin along with diazepam

B  Takes olanzapine along with diazepam

C  Drinks grapefruit juice along with diazepam

D  Takes phenobarbital along with diazepam

A  “Allow at least 8 hours for sleep.”

B  “Take the medication with food or milk.”

C  “Expect and prepare for a daytime hangover.”

D  “Report palpitations to the primary health care provider.”

A  Hypotension, Drug allergy, Status epilepticus

B  Significant respiratory difficulties, Hypotension, Status epilepticus

C  Pregnancy, Drug allergy, Significant respiratory difficulties

D  Hypotension, Status epilepticus, Pregnancy

A  Pentobarbital

B  Thiopental

C  Phenobarbital

D  Butabarbital

A  Causes gastrointestinal distress

B  Impairs coordinated movements

C  Increases pain associated with activities

D  Produces drowsiness, lethargy, and blurred vision

A  Drink coffee or tea in the morning.

B  Avoid using this drug to induce sleep.

C  Take the drug 30 minutes before sleeping.

D  Use the lowest effective dosage.

A  Tonic-clonic seizure

B  Malignant hyperthermia

C  Delirium tremens

D  Respiratory arrest

A  Recommend discussing an alternative drug for seizures with the primary health care provider.

B  Request a prescription to increase the dosage of pentobarbital.

C  Suggest an alternate contraceptive method to the patient.

D  Instruct the patient to increase the dosage of the contraceptive drug.

A  “I will have a glass of warm milk before bed.”

B  “I should avoid exercise just before going to bed.”

C  “I may be prescribed benzodiazepines to promote sleep.”

D  “I will stop drinking coffee at least 6 hours before bedtime.”

A  Administration of intravenous fluids

B  Administration of furosemide

C  Maintenance of an adequate airway

D  Administration of activated charcoal

A  Diazepam, Midazolam, Eszopiclone

B  Zolpidem, Ramelteon, Eszopiclone

C  Diazepam, Ramelteon, Midazolam

D  Zolpidem, Diazepam, Midazolam

A  Take lower doses of benzodiazepines.

B  Drink lactose-free milk at bedtime.

C  Use home remedies of vegetables and herbs.

D  Go to acupuncture therapy.

A  Infusion without dilution

B  Infusion of other drugs

C  Intravenous infiltration

D  Infusion that is too rapid

A  Temazepam induces sleep in approximately 1 hour.

B  Temazepam causes early awakening after sleep.

C  Temazepam may cause gastrointestinal upset.

D  The therapeutic activity of temazepam is reduced with sleep.

A  Duration of action on the central nervous system (CNS)

B  Dose of the drug used to produce the effect on the CNS

C  Degree of inhibition of nerve impulse transmission to the CNS

D  Degree of patient responsiveness to the drug given

A  Naloxone

B  Flumazenil

C  Ipecac syrup

D  Activated charcoal

A  Hallucinations

B  Ataxia

C  Alertness

D  Dyspnea

A  Midazolam

B  Diazepam

C  Flurazepam

D  Temazepam

A  Sleeping more during the day

B  Avoiding tobacco at bedtime

C  Establishing a set sleep pattern

D  Avoiding alcohol at bedtime

A  Diazepam

B  Pentobarbital

C  Ramelteon

D  Zaleplon

A  The patient is experiencing a barbiturate overdose.

B  The patient was administered azole along with benzodiazepine.

C  The patient is experiencing benzodiazepine toxicity.

D  The patient is experiencing a muscle-relaxant overdose.

A  Phenylephrine at a maximum dose of 5 mg

B  Flumazenil at a maximum dose of 3 mg

C  Flumazenil at a maximum dose of 1 mg

D  Phenylephrine at a maximum dose of 2 mg

A  Teaching the patient about meditation

B  Recommending that the patient consume a glass of warm lactose-free milk at bedtime

C  Instructing the patient to take low doses of benzodiazepines

D  Encouraging the patient to maintain a well-balanced diet

A  Amnesic properties

B  Suppression of gamma-aminobutyric acid (GABA) receptors

C  Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

D  Inhibition of nerve impulse transmission

A  Flumazenil

B  Activated charcoal

C  Olanzapine

D  Furosemide

A  Prolonged benzodiazepine action

B  Increased central nervous system (CNS) depression

C  Increased daytime sleepiness

D  Decreased benzodiazepine effects

A  Mephobarbital

B  Phenobarbital

C  Pentobarbital

D  Butabarbital

A  Sulfamethoxazole

B  Ceftriaxone

C  Phenobarbital

D  Oxytocin

A  The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

B  The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

C  The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

D  The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

A  Rifampin

B  Olanzapine

C  Verapamil

D  Flumazenil

A  Constipation

B  Dry mouth

C  Decreased heart rate

D  Amnesia

A  Diazepam

B  Baclofen

C  Cyclobenzaprine

D  Dantrolene

A  Ramelteon

B  Midazolam

C  Eszopiclone

D  Alprazolam

A  Bedwetting

B  Increased perspiration

C  Increased body weight

D  Sleepwalking

A  Reduction of choreiform movement

B  Reduction of muscle rigidity

C  Relief of nerve pain

D  Prevention of lightheadedness

A  Epileptic disease

B  Drug allergy

C  Narrow-angle glaucoma

D  Cardiac disease

A  Short-acting barbiturates

B  Ultra-short-acting barbiturates

C  Long-acting barbiturates

D  Intermediate-acting barbiturates

A  Bedwetting

B  Daytime fatigue

C  Vivid dreams

D  Sleepwalking

A  Relaxation

B  Deep sleep

C  Sleepwalking

D  Dozing

A  Ramelteon

B  Eszopiclone

C  Zaleplon

D  Zolpidem

A  Administer four doses at 15-second intervals.

B  Administer a second dose.

C  Provide another prescribed medication.

D  Continue to monitor consciousness for 2 minutes.